Body weight, though not directly factored into dosing algorithms, influences pharmacokinetics
We also screen for prior pancreatitis, gallbladder disease, and kidney risks
The apparent increased risk of NAION must be considered in context, as GLP-1 receptor drugs have provided considerable benefit to millions of users, including an increased chance of improved management of type 2 diabetes, substantial reduction in body weight, substantially improved morbidity and mortality of major adverse cardiovascular events and even reduced addictive behaviors, they noted
Rats were bred in-house at the Pharmacology animal facility, School of Medicine, Zagreb, Croatia
Critical Functions of Vitamin B12: Your body depends on B12 for DNA synthesis, the process by which cells replicate and repair themselves
The recent setback delays Pfizer's entry into the rapidly growing obesity drug market